Stabilizing biomolecular interactions with synthetic molecules to impact biological function is a concept of enormous appeal. Although much effort has been devoted to disrupting proteinprotein interactions (PPIs) using inhibitors, less attention has been directed toward the reverse strategy, that of inducing new PPIs. However recent years have seen a resurgence of interest in designing molecules that bring proteins together. This approach promises to significantly expand the range of tractable targets for chemical biology and therapeutic intervention. Pioneering structural and biophysical investigation of ternary complexes formed by mono-and bifunctional ligands highlight that proximity-induced stabilization or de novo formation of PPIs are a common feature of their molecular recognition. In this review, we illustrate these concepts and advances with representative case studies, and highlight progress over the past three years, with particular focus on recruitment to E3 ubiquitin ligases by "molecular glues" and chimeric dimerizers (PROTACs) for targeted protein degradation.